PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 16, 2026Nature Communications1 citationsOpen Access

Dissecting origin factors of lymph node metastasis in non-small cell lung cancer via multimodal omics

DCDi CHENDalian Institute of Chemical PhysicsYLYu LiuShanxi Agricultural UniversityDSDaiwang ShiChina Medical University

Key Points

  • The aim is to understand the mechanisms underlying lymph node metastasis in non-small cell lung cancer.
  • Utilized multimodal omics approach to analyze metastatic lymph nodes and primary tumors
  • Characterized cellular and spatial features of tumor regions
  • Evaluated expression levels of relevant proteins such as PD-L1 and FTH1
  • Identified distinct regions in tumors with high stemness and immunoglobulin expression
  • Found increased PD-L1 expression linked to specific malignant cells
  • Revealed macrophage populations and their roles in tumor immunity
  • Highlighted the association of FTH1 with cancer cell stemness and metastasis

Abstract

Cancer metastasis accounts for the majority of cancer-related deaths and lymph node metastasis is critical in cancer staging and prognosis. However, the mechanisms involved in lymph node metastatic non-small cell lung cancer (NSCLC) remain unclear. Here, we delineate the cellular and spatial landscape of metastatic lymph nodes and their matched primary tumors in NSCLC using multimodal omics. In results, tumor core and peripheral regions respectively exhibit high stemness and elevated expression of immunoglobulins. Increased expressions of CD274 (PD-L1) are observed in the immunoglobulin-high malignant cells and SPP1+IFI30+ macrophages. Notably, residual and tertiary lymphoid structures are identified. However, their anti-tumor immunity is compromised by CXCL13+ T cell exhaustion and immune exclusion. Furthermore, we identify the ferroptosis signaling, with its key factor FTH1 showing strong associations with cancer cell stemness and metastasis. This study elucidates the mechanisms of metastasis and immune evasion in lymph node metastatic NSCLC, providing insights for targeted therapies.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

CHEN et al. (2026) studied this question.

synapsesocial.com/papers/69e07c1e2f7e8953b7cbd95bhttps://doi.org/10.1038/s41467-026-71819-9
Ask AI
Helpful
Bookmark
Share
View Full Paper